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Abstract
Purpose: This study aimed to determine analgesic efficacy of a combination of bilateral superficial cervical plexus 
block (BLSCPB) and standard analgesia with standard analgesia alone in patients undergoing thyroid cancer surgery 
under general anaesthesia.
Materials and Methods: It was a randomised-controlled trial conducted at the Anaesthesia Department of the Shaukat 
Khanum Memorial Cancer Hospital, Lahore. A sample size of 60 patients (30 patients in each group) was calculated 
with 95% confidence interval and power of 80%.
Results: The mean pain-free duration for the Group A (BLSCPB group) was 72 min (SD 30.1) compared to 53 min 
(standard deviation 30.3) for the Group B. This shows a significant reduction in pain-free duration in Group A. 
Average NRS pain score in the Group A at q 0, 30, 60, 90 and 120 min was (0.83, 1.83, 0.23, 1.76 and 1.49), whereas 
the average pain score on NRS in the Group B at the same time interval mentioned above for Group A was (2.1, 2.73, 
4.53, 2.44 and 1.85)
Conclusion: Administration of BLSCPB resulted in superior analgesia after thyroid cancer surgery.
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Introduction
Common complications after thyroidectomy are infection, 
vocal cord paralysis, bleeding and post-operative pain. 
Recent advancements have minimised most of these 
surgical complications, but post-operative pain still 
remains as a significant problem, specifically in the 
day care settings.[1] These patients usually complain of 
moderate intensity short duration pain.[2] Up to 90% patient 
receive opioids for its treatment on the 1st post-operative 
day.[3] There is high risk of nausea and vomiting after 
thyroid surgery,[4] and uncontrolled pain can further 
exacerbate this problem. Opioids are the gold standard for 
post-operative pain. Due to their undesirable side effects 
such as nausea and vomiting, sedation and respiratory 
depression, anaesthesia practice has evolved from ‘opioid 
based’ to ‘opioid sparing’ or more recently into ‘opioid 
free anaesthesia.’ This requires non-opioid analgesics 
and use of regional analgesia techniques. Acetaminophen 
is a non-opioid analgesic, which does not cause post-
operative nausea and vomiting, sedation or respiratory 
depression. It is a drug of choice for the management of 
post-operative pain, especially after thyroidectomy.[5] As 
part of multimodal analgesia regional blocks are gaining 
popularity in the management of post-operative pain after 
thyroidectomy.
A study of 162 patients who underwent thyroidectomy 
and received bilateral superficial cervical plexus block 
(BLSCPB), pain score was much lower in the initial 
hours post-surgery that eventually leads to a shortened 
hospital stay. Meantime duration to keep patient pain free 
in Group A (general anaesthesia [GA] + standard analgesia 
JOURNAL OF CANCER & ALLIED SPECIALTIES 2
ORIGINAL ARTICLE J Cancer Allied Spec 2019;5(2):3
along with isotonic saline for BLSCPB) was 82.1 ± 61 min 
versus in Group B (GA + standard analgesia with 0.5% 
bupivacaine for BLSCPB) was 360.8 ± 213.75 min.[6] 
However, another similar study on 111 patients who were 
infiltrated with BLSCPB either before commencement 
or the end of surgery as a regional block with 0.75% 
ropivacaine concluded that there was no improvement 
of post-operative pain score.[7] Alternatively, BLSCPB 
used in-patient undergoing carotid endarterectomy had 
improved analgesic efficacy as compared to combined 
(superficial and deep cervical plexus block) technique.[8-9] 
Hence, information regarding the efficacy of BLSCBPs 
in post-operative analgesia for thyroid surgery has been 
controversial, with some studies[10] proving BLSCBP to 
be effective while other studies[11] finding no effect with 
the same.
Standard intravenous (IV) analgesia has not been 
established in literature; however, multimodal regimen 
currently used in our setup is comparable with other 
researches. These include a combination of opioids, non-
steroidal anti-inflammatory drugs and acetaminophen. For 
this study, we defined standard analgesia as ‘IV morphine 
0.1 mg/kg + 15 mg/kg acetaminophen.’ Since there are 
conflicting reports regarding the efficacy of BLSCPB, we 
used standard analgesia in both groups. In this way, we 
did not deprive our patients the current standard of care 
at our institute.
The aim of this study was to compare the analgesic 
efficacy in terms of duration of pain-free period after the 
administration of BLSCPB and standard analgesia with 
standard analgesia alone. The study outcome can help us 
to develop better analgesic modality for thyroidectomy 
patients. If proven to be efficacious, further studies may 
use cervical plexus block as a stand-alone technique or in 
combination with reduced number or dose of analgesics 
that we currently use as part of our standard regimen.
Objectives
The objective of the study is to compare the mean duration 
of patient’s pain-free time in Group A (standard analgesia 
with BLSCPB) versus in Group B (Standard analgesia 
without BLSCPB) in patients undergoing thyroid cancer 
surgeries.
Operational definitions
Outcome variable was the patient’s pain-free time. After 
the procedure, patients were shifted to post-anaesthesia 
care unit (PACU) where they were evaluated for 
post-operative pain using numeric pain rating score 
(10: The worst pain imaginable and 0: Pain free) at q 0, 
30, 60, 90 and 120 min. When numeric rating score 
was ≥4/10, pain was labeled and duration of pain-free 
time was recorded.
Bilateral superficial cervical plexus blocks
The cervical plexus is made up of the ventral rami of the first 
four spinal nerves, which further distribute in superficial 
or deep motor branches. The block was performed using 
20 ml of 0.25% bupivacaine on each side of the neck 
along the dorsal edge of the sternocleidomastoid muscle.
Standard analgesia
Standard analgesic regimen used in this study was 
intravenous (0.1 mg/kg morphine and 15 mg/kg 
acetaminophen).
Hypothesis
There is a difference in the meantime duration to keep 
patient pain free in standard analgesia with BLSCPB 
versus in patients with standard analgesics without 




This was a prospective, observer-blinded randomised-
controlled trial.
Setting
This study was conducted at the Department of Anaesthesia 
and Pain Medicine, Shaukat Khanum Memorial Cancer 
Hospital and Research Center, Lahore.
Duration of study
6 months. (From September 2017 to March 2018).
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Sample size
Sample size of 60 patients (30 patients in each group) 
calculated based on the pioneer study[10] with 95% 
confidence interval, 80% power of the test and expected 
meantime to keep the patient pain free. A difference 
pain-free duration of 130 min (standard deviation [SD] 





1. American Society of Anesthesiologists (ASA) I and II
2. Patients 20–60 years of age of either gender 
undergoing thyroidectomy for thyroid cancer.
Exclusion criteria
1. Patients refusal for intervention
2. Patient allergic to bupivacaine and opioids
3. Renal abnormality with (creatinine value >2.0)
4. Patients with a history of smoking, chronic narcotic 
use or alcohol abuse.
Data collection
After getting the approval from Hospital Ethics Committee, 
patients who met the inclusion criteria were randomly 
allocated to groups using random number table available 
online. Group A was patients receiving BLSCPB, and 
Group B was patients not receiving BLSCPB. Both groups 
received standard analgesia.
Graph 1: Mean pain score versus time intervals
Table 1: Demographics characters and duration of 
surgery




Age (years) 37.33±10 37.01±8
Weight (kg) 66±9 69±6
Male: Female (n) 3:7 2:8
Duration of surgery (min) 130±41 128±27
Table 2: Mean pain‑free duration with P value




≤30 Group A 10 70±28.5 0.003
Group B 10 49±23.6
≥30 Group A 20 74±31.7 0.048
Group B 20 57±37.0
SD: Standard deviation
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All patients were provided with patient information 
sheet, and written informed consent was obtained. The 
demographic information, ASA status, age and weight 
were noted. IV access was established in all patients, 
and vitals were checked before the induction. Patients 
were shifted to operating room, and ASA standard 
monitoring (electrocardiography, non-invasive blood 
pressure, heart rate and pulse oximetry) was applied. 
A standard anesthetic regimen was applied. Anaesthesia 
was induced with propofol 1–2 mg/kg and muscle 
relaxation with atracurium 0.5 mg/kg. Airway was secured 
by endotracheal tube. All patients were ventilated with 
volume controlled ventilation with a mixture of 50% 
oxygen and 50% air and 1.5–2.5% sevoflurane.
Standard analgesia (0.1 mg/kg morphine and 
15 mg/kg acetaminophen for pain management) was given 
to the patients in both groups. Group A received standard 
analgesia and regional block (BLSCPB) with 20 ml of 
0.25% bupivacaine using 3 point injection technique, and 
the spread of local anaesthesia was visualised with the 
ultrasound machine before the commencement of surgery.
Group B received GA and standard analgesia without the 
regional block (BLSCPB). All patients were administered 
IV fluid consisting of Ringer’s lactate solution for 
maintenance according to patient’s weight.
After the surgery, patients were shifted to the PACU. They 
were evaluated for pain using numeric pain rating score, 
at 0, 30, 60, 90 and 20 min after surgery. If the patient’s 
pain score was higher than four, a rescue analgesia 
of diclofenac 75 mg was given. Pain-free period was 
recorded as per operational definition.
Statistical analysis
Statistical analysis was performed using SPSS version 22 
for IBM (SPSS, Chicago, Illinois, USA). Quantitative 
variable was presented as mean ± SD. Qualitative 
variables such as gender were presented as frequency 
and percentage. Both groups were compared by applying 
t-test. Assumptions for t-test (normality and equality of 
variance) were checked using graphical and statistical 




Table 1 demonstrates demographic characteristic and 
duration of surgery. 10 (33.3%) patients in Group A 
were ≤30 years and 20 (66.6%) patients in Group B were 
more than 30 years of age. Similarly, 10 (33.3%) patients 
in Group A were more ≤30 years of age and 20 (66.6%) 
patients were more than 30 years of age in Group B. Mean 
age of the patients was 37.33 years in the Group A and 
37.0 in Group B, the range being 18–60 years.
Gender distribution
Group A consisted of 21 female (60%) and 9 (30%) male 
patients. Group B consisted of 24 (80%) females and 
6 (20%) males.
Mean pain-free duration (primary outcome)
The mean pain-free duration for the Group A was 72 min 
(± 30.1) compared to a mean free duration of 53 min 
(± 30.3) for Group B.
Patients whose age was ≤30 years in Group A had a 
mean pain-free duration of 70 min (± 28.5) as compared 
to Group B where mean pain-free duration was 49 min 
(± 23.6). Similarly, patients whose age was more than 
30 years in Group A had a mean pain-free duration of 
74 min (± 31.7) as compared to Group B where mean 
pain-free duration was 57 min (± 37). This shows a 
significant reduction in mean pain-free duration in 
Group A population [Table 2].
Mean pain score
Average NRS pain score in the Group A at q 0, 30, 60, 
90 and 120 minutes was (0.83 ± 0.986, 1.83 ± 1.510, 
3.23 ± 1.870, 1.76 ± 1.76 and 1.49 ± 1.495), whereas the 
average NRS pain score in the Group B at q 0, 30, 60, 
90 and 120 minutes was (2.1 ± 2.20, 2.73 ± 2.43, 4.53 ± 
2.65, 2.44 ± 2.44 and 1.85 ± 1.85) [Graph 1].
Discussion
Literature regarding the analgesic efficacy of bilateral 
BLSCPB for post-operative analgesia after thyroidectomy 
remains inclusive. While some studies[6,11] have found no 
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benefit for post-operative pain control with BLSCPSB, 
others advocated BLSCPB as a promising and effective 
analgesic modality in patients undergoing thyroidectomy.[7] 
This study can be differentiated from other similar studies 
as this study included only thyroid carcinoma patients 
undergoing thyroidectomy.
The goal of this study was to compare the analgesic 
efficacy by calculating the mean pain-free duration of the 
BLSCPB group versus the control group. BLSCPB was 
performed immediately after the induction of GA using 
the three-point landmark technique and then visualising 
the spread of bupivacaine with an ultrasound machine. 
We used 0.25% bupivacaine with GA versus standard 
analgesia alone being used at our setup for post-operative 
pain management. There was significant difference in 
pain scores at all time intervals in our study. These results 
suggest that there is a considerable decrease in pain scores 
in the first 2 h after the surgery in the BLSCPB patient as 
compared to the standard analgesia alone group. It was 
also observed that fewer patients in Group A required 
rescue analgesic dose of 75 mg diclofenac as compared 
to the control group.
The choice of drug to be used in the cervical block is 
debatable, and various combinations are recommended in 
different studies. In the study by Andieu et al., clonidine 
was used as an adjuvant with bupivacaine for regional 
anaesthesia, this lead to a significant decrease in peri-
operative analgesic requirement in patients of BLSCPB 
group. Clonidine enhances pain relief after peripheral 
nerve block, acting through a central action due to 
systemic absorption and a direct action on local nerve 
fibres.[12] We did not use clonidine as it is not available 
in our country.
In another study by Eti et al.,[11] patients did not require 
additional analgesia for initial hours when BLSCPB was 
performed at the end of thyroidectomy; furthermore, 34% 
did not require opiates at all in the first 24 h after surgery.
Our results are comparable to available literature. This 
study shows that BLSCPB is an effective method of 
reducing post-operative pain after thyroidectomy. Post-
operative pain was well controlled during the stay in 
PACU. Additional analgesia paracetamol was prescribed 
as the patient was discharged from PACU. This way the 
use of opioid was minimised in the post-operative period 
and hence the associated side effects such as nausea and 
vomiting.
Meantime duration of pain-free period was longer in the 
BLSCPB patients, however  it was shorter than what was 
expected. There could be two possible explanations. First, 
few patients had a previous thyroid surgery which could 
have distorted the anatomical planes of thyroid. This could 
alter the spread of the bupivacaine infiltrated in the region. 
Hence, these patients had a lesser pain satisfaction score, 
some of our patient population consisted of non-Urdu/
English speaking group. We required a translator (usually 
an attendant) to translate the pain score. Language barrier 
and patient apprehension could have been a factor in 
undermining the pain score. Hence, this is considered as 
another limitation of the study.
The pain scores in Group B confirm that some patients 
experience moderate/severe pain (mean pain score 
>4 at 60 min) after surgery but for a short duration. 
Acetaminophen alone was insufficient, and rescue 
analgesic dose of diclofenac 75 mg was added in these 
patients. Hence, regional anaesthesia is an appropriate 
component of multimodal analgesia in this setting.
Conclusion
BLSCPB infiltrated after the induction of GA is effective 
method of reducing post-operative pain after thyroid 
cancer surgery. It also significantly decreases the severity 
of pain in the first 2 h after surgery. Further studies are 
required with larger sample size to establish the role 
of cervical plexus block as an effective modality for 
preventing post-operative pain after thyroid cancer 
surgeries.
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